Richard A. Barasch - 17 Nov 2022 Form 4/A - Amendment Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
By: Mark Hueppelsheuser For: Richard Barasch
Issuer symbol
TOI
Transactions as of
17 Nov 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
30 Dec 2022, 15:38:37 UTC
Date Of Original Report
21 Nov 2022
Previous filing
07 Oct 2022
Next filing
08 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Award $0 +65,174 +46% $0.000000 207,193 17 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is filed to correct the number of restricted stock units granted due to an administrative error in applying the grant amount calculations.
F2 Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date.